Edit company profile
Submit
Picture
2Blades continues broad license access to its award-winning Transcription Activator Like (TALEN) technology for applications in advancing research in genome edi...
NAPIGEN, a company developing proprietary technology to edit mitochondrial and chloroplast genomes, completed a $7.85 million seed funding round.